Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3. - Mahy, P.; de Bast, M.; Leveque, P. H.; Gillart, J.; Labar, D.; Marchand, J.; Gregoire, V. (European Journal of Nuclear Medicine & Molecular Imaging, 2004)